New AI camera technology could offer a future tool for quickly assessing the severity of infections

FHS
June 5, 2024
6:18 pm

It might soon be possible to measure a patient’s pulse, breathing, and blood pressure simply by scanning their face.

Abbott CEO talks diabetes market, device pricing at J.P. Morgan conference

Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Abbott CEO Robert Ford expects the company

January 10, 2024

Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea

Dive Brief: Vivos Therapeutics has received 510(k) clearance for the use of its oral devices in adults with severe obstructive sleep apnea (OSA). The Food

November 30, 2023

AD/PD 2024: Eli Lilly’s donanemab hit with FDA delay – Pharmaceutical Technology

Share this article The approval date for Eli Lilly’s donanemab has been pushed from the previously expected time in 1Q 2024 to a date as

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.